Dr. Jonathan Sheinberg

http://www.goodhealth.com/articles/2006/11/03/healthy habits may not be enough to prevent heart disease 'Diet and exercise are only half of the equation,' says Jonathan Sheinberg, M.D., a cardiologist with Texas Cardiovascular Consultants, P.A. ]]> Fri, 3 Nov 2006 06:00:00 UTC

"Trans fats are dangerous because they cause increased blockages in the arteries and increase risk of cardiac death," said Jonathan Sheinberg, a cardiologist with Texas Cardiovascular Consultants.

Region 7 Dinner Meeting Evaluation and treatment alternatives for the male with ED, presented by Jonathan I. Sheinberg, Staff cardiologist, Wright-Patterson Medical Center, Thursday, March 18, 2004, 6:30 PM arrival and reception, 7:00 PM dinner and lecture.The waterfront, 14 Pete Rose Pier, Covington, Kentucky (859) 5581-1414.

Jonathan Sheinberg, MD

Jonathan Sheinberg, MDOptima Educational Solutions, Inc. - Jonathan Sheinberg, MD
...
Jonathan Sheinberg, MD

Staff CardiologistWright-Patterson Medical Center
...
Jonathan Sheinberg, MD, is Staff Cardiologist, Wright-Patterson Medical Center, Wright-Patterson Air Force Base, Ohio, and Major, USAF, Flight Surgeon.He received his MD degree from Georgetown University School of Medicine, Washington, DC.His clinical appointments include Professor of Medicine, Uniformed University of Health Science and Assistant Clinical Professor of Medicine, Wright State University School of Medicine, in Dayton, Ohio.

Dr. Sheinberg completed fellowship and residency assignments at Wilford Hall USAF Medical Center, Lackland Air Force Base, Texas, and Keesler Medical Center, Keesler Air Force Base, Mississippi.He is board certified in Cardiovascular Disease and Internal Medicine.

An active researcher, Dr. Sheinberg's interests include the predictive value of myocardial perfusion imaging using single photon emission computed tomography in the detection of coronary artery disease and Principal Investigator, PURSUIT (randomized, double-blind evaluation of the efficacy and safety of two dosing regimens of integrelin versus placebo for reducing mortality and myocardial (re)infarction in patients with unstable angina or non-Q wave myocardial infarction).